Huang, L.;                     Li, G.;                     Zhang, Y.;                     Zhao, X.;                     Wang, K.;                     Jia, C.;                     Zhang, W.;                     Tan, J.;                     Chen, X.;                     Li, Q.;     
    et al.    Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. Vaccines 2025, 13, 467. Vaccines 2025, 13, 826.
    https://doi.org/10.3390/vaccines13080826
    AMA Style
    
                                Huang L,                                 Li G,                                 Zhang Y,                                 Zhao X,                                 Wang K,                                 Jia C,                                 Zhang W,                                 Tan J,                                 Chen X,                                 Li Q,         
        et al.        Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. Vaccines 2025, 13, 467. Vaccines. 2025; 13(8):826.
        https://doi.org/10.3390/vaccines13080826
    
    Chicago/Turabian Style
    
                                Huang, Lili,                                 Guangfu Li,                                 Yuhui Zhang,                                 Xue Zhao,                                 Kai Wang,                                 Chunyu Jia,                                 Wei Zhang,                                 Jiebing Tan,                                 Xiaofen Chen,                                 Qin Li,         
         and et al.        2025. "Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. Vaccines 2025, 13, 467" Vaccines 13, no. 8: 826.
        https://doi.org/10.3390/vaccines13080826
    
    APA Style
    
                                Huang, L.,                                 Li, G.,                                 Zhang, Y.,                                 Zhao, X.,                                 Wang, K.,                                 Jia, C.,                                 Zhang, W.,                                 Tan, J.,                                 Chen, X.,                                 Li, Q.,                                 Jiang, H.,                                 An, R.,                                 Leng, W.,                                 Yang, Y.,                                 An, Y.,                                 Wang, Y.,                                 & Zhang, Y.        
        
        (2025). Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. Vaccines 2025, 13, 467. Vaccines, 13(8), 826.
        https://doi.org/10.3390/vaccines13080826